Latest News and Press Releases

RALEIGH, N.C., April 17, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial...

RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding...

RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...

Highlights Combined Company net new business awards of $622.9 million for the fourth quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined...

RALEIGH, N.C., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle...

RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health Communications today released a report that provides pioneering perspectives into patients’ thought processes as they confront a future...

RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017...

RALEIGH, N.C., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that two of its advertising...

RALEIGH, N.C., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO (Contract Commercial...

RALEIGH, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More...